Skip to main content

Advertisement

Log in

Geospatial Variations and Neighborhood Deprivation in Drug-Related Admissions and Overdoses

  • Published:
Journal of Urban Health Aims and scope Submit manuscript

Abstract

Drug overdoses are a national and global epidemic. However, while overdoses are inextricably linked to social, demographic, and geographical determinants, geospatial patterns of drug-related admissions and overdoses at the neighborhood level remain poorly studied. The objective of this paper is to investigate spatial distributions of patients admitted for drug-related admissions and overdoses from a large, urban, tertiary care center using electronic health record data. Additionally, these spatial distributions were adjusted for a validated socioeconomic index called the Area Deprivation Index (ADI). We showed spatial heterogeneity in patients admitted for opioid, amphetamine, and psychostimulant-related diagnoses and overdoses. While ADI was associated with drug-related admissions, it did not correct for spatial variations and could not account alone for this spatial heterogeneity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Visconti AJ, Santos GM, Lemos NP, Burke C, Coffin PO. Opioid overdose deaths in the city and county of San Francisco: prevalence, distribution, and disparities. J Urban Health. 2015;92(4):758–72.

    Article  Google Scholar 

  2. Garfield J. E D: fatal overdose trends in major us cities: 1990–1997. Addiction Research & Thery. 2001;9(5):425–36.

    Article  Google Scholar 

  3. Brownstein JS, Green TC, Cassidy TA, Butler SF. Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse. Pharmacoepidemiol Drug Saf. 2010;19(6):627–37.

    Article  Google Scholar 

  4. Havens JR, Talbert JC, Walker R, Leedham C, Leukefeld CG. Trends in controlled-release oxycodone (OxyContin) prescribing among Medicaid recipients in Kentucky, 1998-2002. J Rural Health. 2006;22(3):276–8.

    Article  Google Scholar 

  5. Dasgupta N, Jonsson Funk M, Brownstein J. Comparing unintentional opioid poisoning mortality in metropolitan and non-metropolitan counties, United States, 1999–2003. In: Thomas Y, Richardson D, Cheung I, editors. Geography and drug addiction. New York: Springer; 2008.

    Google Scholar 

  6. McLafferty S. Placing substance abuse. In: Thomas Y, Richardson D, Cheung I, editors. Geography and drug addiction. New York: Springer; 2008.

    Google Scholar 

  7. Paulozzi LJ, Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med. 2006;31(6):506–11.

    Article  Google Scholar 

  8. Paulozzi LJ, Xi Y. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepidemiol Drug Saf. 2008;17(10):997–1005.

    Article  Google Scholar 

  9. Rigg KK, Monnat SM, Chavez MN. Opioid-related mortality in rural America: geographic heterogeneity and intervention strategies. Int J Drug Policy. 2018;57:119–29.

    Article  Google Scholar 

  10. Zerzan JT, Morden NE, Soumerai S, Ross-Degnan D, Roughead E, Zhang F, et al. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care. 2006;44(11):1005–10.

    Article  Google Scholar 

  11. Health UoWSoMaP: Area Deprivation Index. v2.0 edn. Madison, WI; 2015.

  12. Kind AJ, Jencks S, Brock J, Yu M, Bartels C, Ehlenbach W, et al. Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study. Ann Intern Med. 2014;161(11):765–74.

    Article  Google Scholar 

  13. Lantos PM, Hoffman K, Permar SR, Jackson P, Hughes BL, Kind A, et al. Neighborhood disadvantage is associated with high cytomegalovirus seroprevalence in pregnancy. J Racial Ethn Health Disparities. 2018;5(4):782–6.

    Article  Google Scholar 

  14. Sheets L, Petroski GF, Jaddoo J, Barnett Y, Barnett C, Kelley LEH, et al. The effect of neighborhood disadvantage on diabetes prevalence. AMIA Annu Symp Proc. 2017;2017:1547–53.

    PubMed  Google Scholar 

  15. Singh GK. Area deprivation and widening inequalities in US mortality, 1969-1998. Am J Public Health. 2003;93(7):1137–43.

    Article  Google Scholar 

  16. Besag J, York J, Mollie A. Bayesian image restoration, with two applications in spatial statistics. Ann Inst Stat Math. 1991;43(1):1–49.

    Article  Google Scholar 

  17. Cerda M, Ransome Y, Keyes KM, Koenen KC, Tardiff K, Vlahov D, et al. Revisiting the role of the urban environment in substance use: the case of analgesic overdose fatalities. Am J Public Health. 2013;103(12):2252–60.

    Article  Google Scholar 

  18. Cerda M, Ransome Y, Keyes KM, Koenen KC, Tracy M, Tardiff KJ, et al. Prescription opioid mortality trends in New York City, 1990-2006: examining the emergence of an epidemic. Drug Alcohol Depend. 2013;132(1–2):53–62.

    Article  Google Scholar 

  19. Green CR, Ndao-Brumblay SK, West B, Washington T. Differences in prescription opioid analgesic availability: comparing minority and white pharmacies across Michigan. J Pain. 2005;6(10):689–99.

    Article  Google Scholar 

  20. Burgess DJ, Phelan S, Workman M, Hagel E, Nelson DB, Fu SS, et al. The effect of cognitive load and patient race on physicians’ decisions to prescribe opioids for chronic low back pain: a randomized trial. Pain Med. 2014;15(6):965–74.

    Article  Google Scholar 

  21. Piercefield E, Archer P, Kemp P, Mallonee S. Increase in unintentional medication overdose deaths: Oklahoma, 1994-2006. Am J Prev Med. 2010;39(4):357–63.

    Article  Google Scholar 

  22. Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300(22):2613–20.

    Article  CAS  Google Scholar 

  23. Joynt M, Train MK, Robbins BW, Halterman JS, Caiola E, Fortuna RJ. The impact of neighborhood socioeconomic status and race on the prescribing of opioids in emergency departments throughout the United States. J Gen Intern Med. 2013;28(12):1604–10.

    Article  Google Scholar 

  24. Ndlovu M, Bedson J, Jones PW, Jordan KP. Pain medication management of musculoskeletal conditions at first presentation in primary care: analysis of routinely collected medical record data. BMC Musculoskelet Disord. 2014;15:418.

    Article  Google Scholar 

  25. Gebauer S, Salas J, Scherrer JF. Neighborhood socioeconomic status and receipt of opioid medication for new back pain diagnosis. J Am Board Fam Med. 2017;30(6):775–83.

    Article  Google Scholar 

  26. Durfey SNM, Kind AJH, Buckingham WR, DuGoff EH, Trivedi AN. Neighborhood disadvantage and chronic disease management. Health Serv Res. 2019;54(Suppl 1):206–16.

    Article  Google Scholar 

  27. Ho JY. The contribution of drug overdose to educational gradients in life expectancy in the United States, 1992-2011. Demography. 2017;54(3):1175–202.

    Article  Google Scholar 

  28. Pouget ER, Fong C, Rosenblum A. Racial/ethnic differences in prevalence trends for heroin use and non-medical use of prescription opioids among entrants to opioid treatment programs, 2005-2016. Subst Use Misuse. 2018;53(2):290–300.

    Article  Google Scholar 

  29. McClellan CB. Disparities in opioid related mortality between United States counties from 2000 to 2014. Drug Alcohol Depend. 2019;199:151–8.

    Article  Google Scholar 

  30. Mosher H, Zhou Y, Thurman AL, Sarrazin MV, Ohl ME. Trends in hospitalization for opioid overdose among rural compared to urban residents of the United States, 2007-2014. J Hosp Med. 2017;12(11):925–9.

    Article  Google Scholar 

  31. Wagner J, Neitzke-Spruill L, O’Connell D, Highberger J, Martin SS, Walker R, et al. Understanding geographic and neighborhood variations in overdose death rates. J Community Health. 2019;44(2):272–83.

    Article  Google Scholar 

  32. Strom BL. Data validity issues in using claims data. Pharmacoepidemiol Drug Saf. 2001;10(5):389–92.

    Article  CAS  Google Scholar 

  33. Seth P, Scholl L, Rudd RA, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants - United States, 2015-2016. MMWR Morb Mortal Wkly Rep. 2018;67(12):349–58.

    Article  Google Scholar 

  34. Presription Drug Overdose Data & Statistics - Guide to ICD-9-CM and ICD-10 Codes Related to Poisoning and Pain. In: Prevention DoUI, Version 1.3 editor. Atlanta, GA: National Center for Injury Prevention and Control - Centers for Disease Control and Prevention; 2013.

Download references

Acknowledgements

We would like to thank Dr. Thomas E. Buccheit and Dr. Steven D. Prakken for their discussion and brainstorming during the early phases of this project.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Julien Cobert.

Ethics declarations

This study was approved by the Duke University Institutional Review Board. A waiver of informed consent was approved for this retrospective study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 21 kb)

ESM 2

(DOCX 13 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cobert, J., Lantos, P.M., Janko, M.M. et al. Geospatial Variations and Neighborhood Deprivation in Drug-Related Admissions and Overdoses. J Urban Health 97, 814–822 (2020). https://doi.org/10.1007/s11524-020-00436-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11524-020-00436-8

Keywords